Ventas, Inc.
$58.57B- Market cap
- $46.30B
- Debt
- +$13.01B
- Cash
- −$741.07M
Capital structure 78% equity / 22% debt · EV / Revenue 10.04x · EV / EBITDA 39.88x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $46.30B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: VTR stock price vs VALE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VALE's multiple
Needs VALE P/E.
Implied fair value · at VTR's multiple
Needs EPS (TTM).
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: VTR FY 2025 (ended Dec 31, 2025) · VALE FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 78% equity / 22% debt · EV / Revenue 10.04x · EV / EBITDA 39.88x
Capital structure 56% equity / 44% debt · EV / Revenue 2.86x
VALE carries the larger enterprise value at $109.99B against $58.57B; VALE trades on the lower EV / Revenue multiple (2.86x vs 10.04x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Ventas, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
VALE S.A. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.04x
—
Net debt / EBITDA
Leverage against operating earnings
8.35x
—
Cash and equivalents
Liquid reserves on the balance sheet
$741.07M
$7.37B
Total debt
Interest-bearing obligations outstanding
$13.01B
$52.18B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
WELLTOWER INC.
VTR vs WELL
Sabra Health Care REIT, Inc.
VTR vs SBRA
NATIONAL HEALTH INVESTORS INC
VTR vs NHI
OMEGA HEALTHCARE INVESTORS INC
VTR vs OHI
BHP Group Ltd
VTR vs BHP
FREEPORT-MCMORAN INC
VTR vs FCX
SOUTHERN COPPER CORP/
VTR vs SCCO
NEWMONT Corp /DE/
VTR vs NEM
TECK RESOURCES LTD
VTR vs TECK
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.